Next Article in Journal
Cavitation Feedback Control of Focused Ultrasound Blood-Brain Barrier Opening for Drug Delivery in Patients with Parkinson’s Disease
Next Article in Special Issue
Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy
Previous Article in Journal
Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System
Previous Article in Special Issue
Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(12), 2606; https://doi.org/10.3390/pharmaceutics14122606
Action Date Notes Link
article xml file uploaded 26 November 2022 08:47 CET Original file -
article xml uploaded. 26 November 2022 08:47 CET Update https://www.mdpi.com/1999-4923/14/12/2606/xml
article pdf uploaded. 26 November 2022 08:47 CET Version of Record https://www.mdpi.com/1999-4923/14/12/2606/pdf
article html file updated 26 November 2022 08:48 CET Original file -
article html file updated 1 March 2023 01:03 CET Update -
article html file updated 3 March 2023 23:05 CET Update https://www.mdpi.com/1999-4923/14/12/2606/html
Back to TopTop